Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-01468 | DM1-PEG4-DBCO | |
| DM1-(PEG)4-DBCO is a drug conjugate (ADC) consisting of the tubulin inhibitor DM1 and the linker DBCO-PEG4-Ahx. Mertansin (DM1), a tubulin inhibitor, is an antibody-conjugated maytansine developed to overcome the systemic toxicity associated with maytansine and enhance tumor-specific delivery. | Inquiry | |
| BADC-01469 | Sulfo-SPDB-DGN462 | |
| Sulfo-SPDB-DGN462 is an extraordinary biomedicine chemical, exhibits unrivaled capabilities in combatting a multitude of diseases and ailments. Its mesmerizing prowess as an unparalleled inhibitor against a specific cadre of enzymes renders it immensely efficacious in curbing the malignant proliferation of cancer cells, subduing infirmities born out of inflammation, and addressing maladies pertaining to the neural system. | Inquiry | |
| BADC-01470 | MC-Val-Cit-PAB-dimethylDNA31 | 1639352-06-9 |
| MC-Val-Cit-PAB-dimethylDNA31 has a bioreversible linkage based on a quaternary ammonium for targeted delivery and it can improve pharmacokinetics and the therapeutic index. MC-Val-Cit-PAB-dimethylDNA31 is used for the antibody-drug conjugates (ADC) that are effective and stable in vitro and in vivo to treat various diseases or disorders. | Inquiry | |
| BADC-01471 | TLR7/8 agonist 4 hydroxy-PEG10-acid | 2388520-17-8 |
| TLR7/8 agonist 4 hydroxy-PEG10-acid (compound 9) is part of an antibody-drug conjugate composed of TLR7/8 activator TLR7/8 agonist 4 (HY-139018) and degradable ADC linker hydroxy-PEG10- acid (HY-133307) concatenated. | Inquiry | |
| BADC-01472 | MAC-VC-PABC-ST7612AA1 | |
| MAC-VC-PABC-ST7612AA1 is part of Antibody Drug Conjugate ADCs with HDAC inhibitor payload and linker for antitumor activity. | Inquiry | |
| BADC-01473 | MC-VC-PABC-SP 141 | |
| MC-VC-PABC-SP 141 is part of an antibody-drug conjugate, which is composed of a potent MDM2 inhibitor SP 141 and a degradable ADC linker MC-VC-PABC. | Inquiry | |
| BADC-01474 | PSMA-ALB-56 | 2306049-48-7 |
| PSMA-ALB-56 is a PSMA-targeting radioligand consisting of a glutamate-urea PSMA-binding entity and an albumin conjugate. | Inquiry | |
| BADC-01475 | N3-PEG8-Phe-Lys-PABC-Gefitinib | |
| N3-PEG8-Phe-Lys-PABC-Gefitinib is composed of anticancer drug Gefitinib (an oral active inhibitor) and degradable ADC linker N3-PEG8-Phe-Lys-PABC. | Inquiry | |
| BADC-01476 | FCHFHS-ST7612AA1 | |
| FCHFHS-ST7612AA1 is part of Antibody Drug Conjugate ADCs with HDAC inhibitor payload and linker for antitumor activity. | Inquiry | |
| BADC-01535 | MC-VC-PAB-Tubulysin M | 1639939-56-2 |
| MC-VC-PAB-Tubulysin M is a potent antibody-drug conjugate used in the treatment of various cancers, including breast, lung, and ovarian cancers. It combines the targeted delivery of an antibody with the cytotoxic effects of Tubulysin M, inhibiting microtubule formation and inducing cell death. | Inquiry | |
| BADC-01536 | DBCO-Peg4-VC-PAB-MMAE | 2129164-91-4 |
| DBCO-Peg4-VC-PAB-MMAE is a cytotoxin and linker conjugate widely used in ADCs. | Inquiry | |
| BADC-01626 | CL2A-SN-38 DCA | |
| CL2A-SN-38 is a drug-linker conjugate composed of a potent DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to make antibody-drug conjugate (ADC). It has significant specific antitumor effects on a variety of human solid tumor types. | Inquiry | |
| BADC-01669 | VA-PAB-PBD | 1595275-60-7 |
| A payload-linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry |
